MAXIMIZING ONCOLOGY STUDY WITH INTEGRATED KRAS ASSAY PROVIDERS AND RAS ASSAYS

while in the swiftly evolving field of oncology investigation, exact and successful mutation screening is critical for building focused therapies. The KRAS providers Platform plays a pivotal job Within this landscape by offering detailed answers for KRAS mutation profiling and Evaluation. KRAS mutations, located in close to 95% of RAS-similar oncog